Elevated IL-6 levels may also be associated with psychological complications, the occurrence of anxiety or depression, which negatively affect rehabilitation outcomes, the effectiveness of neurotrophic agents, and even mortality in patients with AIS [78,79]. The gene discussed is IL6; the disease is depressive disorder.